Skip to main content
Erschienen in: Journal of Neurology 4/2019

01.02.2019 | Original Communication

High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis

verfasst von: Simon Gamraoui, Guillaume Mathey, Marc Debouverie, Catherine Malaplate, René Anxionnat, Francis Guillemin, Jonathan Epstein

Erschienen in: Journal of Neurology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

The 2017 revision of the McDonald criteria highlights the usefulness of cerebrospinal fluid (CSF) immunoglobulin G (IgG) analysis to diagnose multiple sclerosis (MS). The objective of this study was to assess the diagnostic performances of CSF IgG analysis in the absence of a gold standard.

Methods

All patients who underwent CSF IgG analysis for events suggestive of MS in Nancy University Hospital (France) from 2008 to 2011 were retrospectively included. A latent class analysis with Bayesian approach was used to infer MS prevalence (latent variable) as well as the diagnostic properties of the 2005 and 2010 McDonald criteria and CSF IgG analysis (observed variables).

Results

Data from 673 patients were analysed. For CSF IgG analysis, the Bayesian latent class analysis estimated sensitivity of 0.93 (95% CrI 0.89–0.96) and specificity of 0.81 (95% CrI 0.77–0.85). The true prevalence estimate was 36% (95% CrI 0.33–0.40). Sensitivity and specificity estimates for patients with events suggestive of remitting-onset MS were similar to those for the whole sample—0.92 (95% CrI 0.85–0.96) and 0.80 (95% CrI 0.76–0.84), respectively—but higher for patients with signs of progressive-onset MS—0.95 (95% CrI 0.84–0.99) and 0.88 (95% CrI 0.78–0.94), respectively.

Conclusions

In the absence of a gold standard, latent class analysis indicates good diagnostic properties of CSF IgG analysis for MS. This test could thus be useful, especially for patients who tested negative for the 2005 and 2010 McDonald criteria. These findings deserve to be confirmed prospectively.
Literatur
1.
Zurück zum Zitat Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, Mcdowell F et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568CrossRefPubMed Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, Mcdowell F et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–568CrossRefPubMed
2.
Zurück zum Zitat Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231CrossRefPubMed Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13(3):227–231CrossRefPubMed
3.
Zurück zum Zitat McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRef McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50(1):121–127CrossRef
4.
Zurück zum Zitat Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L et al (2005 Dec) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 58(6):840–846CrossRefPubMed Polman CH, Reingold SC, Edan G, Filippi M, Hartung H-P, Kappos L et al (2005 Dec) Diagnostic criteria for multiple sclerosis: 2005 revisions to the ‘McDonald Criteria’. Ann Neurol 58(6):840–846CrossRefPubMed
5.
Zurück zum Zitat Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302CrossRefPubMedPubMedCentral Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292–302CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173CrossRefPubMed Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162–173CrossRefPubMed
7.
Zurück zum Zitat Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C et al (2015) Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain J Neurol 138(Pt 7):1863–1874CrossRef Tintore M, Rovira À, Río J, Otero-Romero S, Arrambide G, Tur C et al (2015) Defining high, medium and low impact prognostic factors for developing multiple sclerosis. Brain J Neurol 138(Pt 7):1863–1874CrossRef
8.
Zurück zum Zitat Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J et al (2015) Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study. Mult Scler Houndmills Basingstoke Engl 21(8):1013–1024CrossRef Kuhle J, Disanto G, Dobson R, Adiutori R, Bianchi L, Topping J et al (2015) Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study. Mult Scler Houndmills Basingstoke Engl 21(8):1013–1024CrossRef
9.
Zurück zum Zitat Arrambide G, Tintore M, Espejo C, Auger C, Castillo M, Río J et al (2018) The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain J Neurol 141(4):1075–1084CrossRef Arrambide G, Tintore M, Espejo C, Auger C, Castillo M, Río J et al (2018) The value of oligoclonal bands in the multiple sclerosis diagnostic criteria. Brain J Neurol 141(4):1075–1084CrossRef
10.
Zurück zum Zitat Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol. 2013;262(1–2):1–10CrossRefPubMed Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol. 2013;262(1–2):1–10CrossRefPubMed
11.
Zurück zum Zitat Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, LORSEP Group (2008) Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 15(9):916–921CrossRefPubMed Debouverie M, Pittion-Vouyovitch S, Louis S, Guillemin F, LORSEP Group (2008) Natural history of multiple sclerosis in a population-based cohort. Eur J Neurol 15(9):916–921CrossRefPubMed
12.
Zurück zum Zitat El Adssi H, Debouverie M, Guillemin F, LORSEP Group (2012) Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method. Mult Scler Houndmills Basingstoke Engl 18(9):1244–1250CrossRef El Adssi H, Debouverie M, Guillemin F, LORSEP Group (2012) Estimating the prevalence and incidence of multiple sclerosis in the Lorraine region, France, by the capture-recapture method. Mult Scler Houndmills Basingstoke Engl 18(9):1244–1250CrossRef
13.
Zurück zum Zitat Housley WJ, Pitt D, Hafler DA (2015) Biomarkers in multiple sclerosis. Clin Immunol Orlando Fla 161(1):51–58CrossRef Housley WJ, Pitt D, Hafler DA (2015) Biomarkers in multiple sclerosis. Clin Immunol Orlando Fla 161(1):51–58CrossRef
14.
Zurück zum Zitat Green BF. A general solution for the latent class model of latent structure analysis. Psychometrika. 1951;16(2):151–166CrossRefPubMed Green BF. A general solution for the latent class model of latent structure analysis. Psychometrika. 1951;16(2):151–166CrossRefPubMed
15.
Zurück zum Zitat Rindskopf D, Rindskopf W (1986) The value of latent class analysis in medical diagnosis. Stat Med 5(1):21–27CrossRefPubMed Rindskopf D, Rindskopf W (1986) The value of latent class analysis in medical diagnosis. Stat Med 5(1):21–27CrossRefPubMed
16.
Zurück zum Zitat Hui SL, Zhou XH (1998) Evaluation of diagnostic tests without gold standards. Stat Methods Med Res 7(4):354–370CrossRefPubMed Hui SL, Zhou XH (1998) Evaluation of diagnostic tests without gold standards. Stat Methods Med Res 7(4):354–370CrossRefPubMed
17.
Zurück zum Zitat Garrett ES, Eaton WW, Zeger S (2002) Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach. Stat Med 21(9):1289–1307CrossRefPubMed Garrett ES, Eaton WW, Zeger S (2002) Methods for evaluating the performance of diagnostic tests in the absence of a gold standard: a latent class model approach. Stat Med 21(9):1289–1307CrossRefPubMed
18.
Zurück zum Zitat Joseph L, Gyorkos TW, Coupal L (1995) Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol 141(3):263–272CrossRefPubMed Joseph L, Gyorkos TW, Coupal L (1995) Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. Am J Epidemiol 141(3):263–272CrossRefPubMed
19.
Zurück zum Zitat Dendukuri N, Joseph L (2001) Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 57(1):158–167CrossRefPubMed Dendukuri N, Joseph L (2001) Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 57(1):158–167CrossRefPubMed
20.
Zurück zum Zitat Ling DI, Pai M, Schiller I, Dendukuri N (2014) A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard. BMC Med Res Methodol 14:67CrossRefPubMedPubMedCentral Ling DI, Pai M, Schiller I, Dendukuri N (2014) A Bayesian framework for estimating the incremental value of a diagnostic test in the absence of a gold standard. BMC Med Res Methodol 14:67CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dendukuri N, Bélisle P, Joseph L (2010) Bayesian sample size for diagnostic test studies in the absence of a gold standard: comparing identifiable with non-identifiable models. Stat Med 29(26):2688–2697CrossRefPubMed Dendukuri N, Bélisle P, Joseph L (2010) Bayesian sample size for diagnostic test studies in the absence of a gold standard: comparing identifiable with non-identifiable models. Stat Med 29(26):2688–2697CrossRefPubMed
22.
Zurück zum Zitat Torrance-Rynard VL, Walter SD (1997) Effects of dependent errors in the assessment of diagnostic test performance. Stat Med 16(19):2157–2175CrossRefPubMed Torrance-Rynard VL, Walter SD (1997) Effects of dependent errors in the assessment of diagnostic test performance. Stat Med 16(19):2157–2175CrossRefPubMed
23.
Zurück zum Zitat de Seze J, Debouverie M, Waucquier N, Steinmetz G, Pittion S, Zephir H et al (2007) Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria. Mult Scler Houndmills Basingstoke Engl 13(5):622–625CrossRef de Seze J, Debouverie M, Waucquier N, Steinmetz G, Pittion S, Zephir H et al (2007) Primary progressive multiple sclerosis: a comparative study of the diagnostic criteria. Mult Scler Houndmills Basingstoke Engl 13(5):622–625CrossRef
24.
Zurück zum Zitat Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6(8):677–686CrossRef Swanton JK, Rovira A, Tintore M, Altmann DR, Barkhof F, Filippi M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6(8):677–686CrossRef
26.
27.
Zurück zum Zitat Gómez-Moreno M, Díaz-Sánchez M, Ramos-González A (2012) Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes. Mult Scler Houndmills Basingstoke Engl 18(1):39–44CrossRef Gómez-Moreno M, Díaz-Sánchez M, Ramos-González A (2012) Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes. Mult Scler Houndmills Basingstoke Engl 18(1):39–44CrossRef
28.
Zurück zum Zitat Villar LM, García-Barragán N, Sádaba MC, Espiño M, Gómez-Rial J, Martínez-San Millán J et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci. 2008;266(1–2):34–37CrossRefPubMed Villar LM, García-Barragán N, Sádaba MC, Espiño M, Gómez-Rial J, Martínez-San Millán J et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Neurol Sci. 2008;266(1–2):34–37CrossRefPubMed
29.
Zurück zum Zitat Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y et al (2014) Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult Scler Houndmills Basingstoke Engl 20(4):458–463CrossRef Kang H, Metz LM, Traboulsee AL, Eliasziw M, Zhao GJ, Cheng Y et al (2014) Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes. Mult Scler Houndmills Basingstoke Engl 20(4):458–463CrossRef
30.
Zurück zum Zitat Nielsen JM, Uitdehaag BMJ, Korteweg T, Barkhof F, Polman CH (2010) Performance of the Swanton multiple sclerosis criteria for dissemination in space. Mult Scler Houndmills Basingstoke Engl 16(8):985–987CrossRef Nielsen JM, Uitdehaag BMJ, Korteweg T, Barkhof F, Polman CH (2010) Performance of the Swanton multiple sclerosis criteria for dissemination in space. Mult Scler Houndmills Basingstoke Engl 16(8):985–987CrossRef
31.
Zurück zum Zitat Caudie C, Birouk AM, Bancel J, Claudy D, Gignoux L, Vukusic S et al (2005) Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis. Pathol Biol (Paris) 53(2):68–74CrossRef Caudie C, Birouk AM, Bancel J, Claudy D, Gignoux L, Vukusic S et al (2005) Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis. Pathol Biol (Paris) 53(2):68–74CrossRef
32.
Zurück zum Zitat Falip M, Tintoré M, Jardí R, Duran I, Link H, Montalbán X. Clinical usefulness of oligoclonal bands. Rev Neurol. 2001;32(12):1120–1124PubMed Falip M, Tintoré M, Jardí R, Duran I, Link H, Montalbán X. Clinical usefulness of oligoclonal bands. Rev Neurol. 2001;32(12):1120–1124PubMed
33.
Zurück zum Zitat Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D et al (2004) CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol 11(8):525–529CrossRefPubMed Bourahoui A, De Seze J, Guttierez R, Onraed B, Hennache B, Ferriby D et al (2004) CSF isoelectrofocusing in a large cohort of MS and other neurological diseases. Eur J Neurol 11(8):525–529CrossRefPubMed
Metadaten
Titel
High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis
verfasst von
Simon Gamraoui
Guillaume Mathey
Marc Debouverie
Catherine Malaplate
René Anxionnat
Francis Guillemin
Jonathan Epstein
Publikationsdatum
01.02.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 4/2019
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09212-4

Weitere Artikel der Ausgabe 4/2019

Journal of Neurology 4/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.